Halozyme Therapeutics
HALO
#2390
Rank
HK$48.52 B
Marketcap
HK$381.42
Share price
7.22%
Change (1 day)
21.97%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): HK$3.74 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are HK$0.94 Billion. In 2023 the company made an earning of HK$2.71 Billion, an increase over its 2022 earnings that were of HK$1.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.74 B38.12%
2023 HK$2.71 B39.94%
2022 HK$1.93 B0.16%
2021 HK$1.93 B92.2%
2020 HK$1.00 B-278.96%
2019 -HK$0.57 Billion-9.45%
2018 -HK$0.63 Billion-229.51%
2017 HK$0.47 B-160.48%
2016 -HK$0.8 Billion216.03%
2015 -HK$0.26 Billion-52.86%
2014 -HK$0.54 Billion-18.09%
2013 -HK$0.65 Billion55.88%
2012 -HK$0.42 Billion169.94%
2011 -HK$0.16 Billion-63.44%
2010 -HK$0.43 Billion-7.19%
2009 -HK$0.46 Billion15.91%
2008 -HK$0.4 Billion83.89%
2007 -HK$0.22 Billion78.1%
2006 -HK$0.12 Billion16%
2005 -HK$0.11 Billion45.24%
2004 -HK$71.15 Million682.42%
2003 -HK$9.1 Million1659.12%
2002 -HK$0.52 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.10 B-97.11%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.01 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.59 Billion-115.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$9.44 Billion-352.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.66 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
HK$143.18 B 3,731.55%๐Ÿ‡บ๐Ÿ‡ธ USA